Search Legislation

Pharmacy Act 1954

What Version

 Help about what version

Advanced Features

 Help about advanced features

Status:

This version of this Act contains provisions that are prospective. Help about Status

Close

Status

The term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section. A version of a provision is prospective either:

  1. where the provision (Part, Chapter or section) has never come into force or;
  2. where the text of the provision is subject to change, but no date has yet been appointed by the appropriate person or body for those changes to come into force.

Commencement Orders listed in the ‘Changes to Legislation’ box as not yet applied may bring this prospective version into force.

Changes to legislation:

There are outstanding changes not yet made by the legislation.gov.uk editorial team to Pharmacy Act 1954. Any changes that have already been made by the team appear in the content and are referenced with annotations. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.

Changes and effects yet to be applied to :

 Help about changes and effects
Close

Changes and effects

This section lists the changes and effects yet to be applied to the specific provision you are viewing.

Changes and effects yet to be applied to the whole Act associated Parts and Chapters:

 Help about changes and effects
Close

Changes and effects

This section lists the changes and effects yet to be applied to the whole Act, associated Parts and Chapters where applicable. This includes any insertions of whole new Parts, Chapters or provisions yet to be inserted into this Act. These effects are included in this view as they may be (but won’t necessarily be) relevant to the specific provision that you are viewing.

Whole provisions yet to be inserted into this Act (including any effects on those provisions):

Commencement Orders yet to be applied to the Pharmacy Act 1954

 Help about changes and effects
Close

Commencement Orders

This section lists the commencement orders yet to be applied to the whole Act. These effects are included in this view as they may be (but won’t necessarily be) relevant to the specific provision that you are viewing. Where applicable the commencement orders are listed under two headings, firstly those that bring some part of the Act you are viewing into force and secondly, those that bring into force legislation that affects some part of the legislation you are viewing. If you are viewing a prospective version or there is a prospective version available there may be commencement orders listed here that are relevant to the provision you are viewing.

Commencement Orders bringing legislation that affects this Act into force:

Registration of pharmaceutical chemistsE+W+S

1 Appointment of registrar and other officers.E+W+S

(1)The Council of the Pharmaceutical Society of Great Britain shall keep a fit and proper person appointed as registrar for the purposes of this Act, and may, for those purposes, appoint a deputy registrar and such clerks and other subordinate officers as the Council think fit.

(2)The Council may pay a suitable salary to any person appointed in pursuance of this section.

(3)The Council may terminate the appointment of any person so appointed.

2 The registers and registration.E+W+S

(1)It shall be the duty of the registrar—

(a)to maintain, in accordance with byelaws and the provisions of this Act, the Register of Pharmaceutical Chemists established in pursuance of the M1Pharmacy Act 1852, which shall contain the names and addresses, and such other particulars (if any) as are prescribed, of all persons who in accordance with those provisions are entitled to have their names registered;

(b)to cause to be prepared, in such form as is for the time being prescribed, and to be printed, published and put on sale in every year, a list (to be known as “The Annual Register of Pharmaceutical Chemists”) of all names which were on the register on the last day of the preceding year.

(2)Subject to the provisions of this Act, a person shall be entitled to have his name registered if he—

(a)satisfies the registrar, or on appeal the Council, that, in accordance with provisions of [F1section 3 or 4A of this Act] or of any byelaw made under section four of this Act, he is qualified to have his name registered; and

(b)pays to the Society such fee in respect of the registration as is prescribed;

and different fees may be prescribed in relation to registrations in pursuance of different provisions mentioned in paragraph (a) of this subsection.

(3)Every registered pharmaceutical chemist shall pay to the Society such fee as is prescribed in respect of the retention of his name on the register in any year or, in the case of a person whose name is first registered in or after the year in which this Act comes into operation (other than a person whose name has at any time been registered under the M2Pharmacy Act 1868) in respect of such retention in any year subsequent to the year in which his name is first registered; and different fees may be prescribed for different classes of registered pharmaceutical chemists, and provision may be made by byelaws for exempting any class of registered pharmaceutical chemists from liability to pay any such fee.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F1Words substituted by S.I. 1987/2202, art. 2(2)

Marginal Citations

3 Qualification by examination for registration.E+W+S

(1)It shall be the duty of the Council to appoint examiners to hold examinations for the purposes of this Act (including separate examiners for Scotland to hold examinations at such place or places in Scotland as the Council determine); but the appointment of any person as such an examiner shall not—

(a)take effect until it is approved by the Privy Council;

(b)continue in force for more than five years from the date on which it is made.

(2)Such examination fee as is prescribed shall be payable to the Society by every candidate at any such examination.

(3)It shall be the duty of the Society to permit any person appointed in that behalf by the Privy Council to be present throughout any such examination.

(4)The subjects at any such examination shall be the latin language, botany, materia medica, pharmaceutical and general chemistry and such other subjects (excluding the theory and practice of medicine, surgery and midwifery) as are prescribed; and byelaws may provide—

(a)for periods of time and courses of study in connection with such examinations and for dividing such examinations into two or more parts;

(b)that no person may be a candidate at any such examination unless he satisfies the Council that he has received such a general education as the Council consider adequate for a registered pharmaceutical chemist;

(c)that no such certificate as is mentioned in the next following subsection shall be granted to any person in consequence of any such examination unless he satisfies the Council that he has received such practical training in the subjects of the examination as the Council consider adequate.

(5)Subject to the foregoing provisions of this section, the examiners may grant a certificate of competence to practise as a pharmaceutical chemist to any person who satisfies them at any such examination that he is competent so to practise; and a person to whom such a certificate is granted shall be qualified to have his name registered.

4 Qualification by degree, diploma, etc. for registration.E+W+S

(1)Byelaws may provide that any person who satisfies such conditions as to character and otherwise as are prescribed by the byelaws and either holds or has held a degree granted in respect of pharmacy by any university in the United Kingdom or a diploma granted in respect of pharmacy in any place outside the United Kingdom or has passed the examinations necessary for obtaining such a diploma shall be qualified to have his name registered—

(a)without his qualifying to have his name registered in accordance with the requirements of the last foregoing section and of byelaws made thereunder; or

(b)upon his so qualifying in accordance with those requirements relaxed to the prescribed extent.

(2)Byelaws may provide that any person who is—

(a)a qualified military dispenser; or

(b). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F2

(c)registered as a pharmaceutical chemist in Northern Ireland,

and who satisfies the Council that he has sufficient skill and knowledge to practise as a pharmaceutical chemist shall be qualified to have his name registered without his qualifying as mentioned in paragraph (a) of the last foregoing subsection.

[F3(3)The references in subsection (1) above to a diploma granted in respect of pharmacy in any place outside the United Kingdom shall not include references to a diploma by which a person is qualified by virtue of section 4A(2)(a) of this Act to have his name registered.]

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

[F44A Qualification by appropriate European diploma for registrationE+W+S
Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

(1)Any national of a member State who holds an appropriate European diploma and satisfies such conditions (if any) as to character and as to physical and mental health as may be prescribed shall be qualified to have his name registered; and where a name is registered by virtue of this section an indication that the name has been registered in respect of an appropriate European diploma shall be entered in the register against that name.

[F5(1A)Any person who—

(a)is not a national of a member State, but

(b)is, by virtue of a right conferred by Article 11 of Council Regulation (EEC) No. 1612/68 F6 or any other enforceable Community right, entitled to be treated, for the purposes of access to the profession of pharmacy, no less favourably than a national of such a State,

shall be treated for the purposes of subsection (1) above as if he were such a national.]

(2)Subject to subsections (3) to (5) of this section, the following diplomas are appropriate European diplomas for the purposes of this section, namely—

(a)any diploma specified in Schedule 1A to this Act; F7. . .

(b)any diploma in pharmacy which is not so specified but has been granted in a member State either before the implementation date or to a person who commenced the training of which the diploma is evidence before that date.

[F8(c)any diploma in pharmacy which is not so specified but is evidence of training commenced before 3rd October 1990 and undertaken on the territory of the former German Democratic Republic.]

(3)A diploma granted in a member State before the implementation date or granted to a person who began the training of which the diploma is evidence before that date is not an appropriate European diploma for the purposes of this section unless—

(a)in the case of a diploma specified in Schedule 1A to this Act, either—

(i)the diploma [F9is evidence of] training that would have satisfied the requirements laid down by the Pharmacists Training Directive; or

(ii)the competent authorities of any member State have certified that the holder of the diploma has lawfully practised pharmacy for at least three consecutive years during the five years preceding the date of the certificate;

or

[F10(b)in the case of any diploma falling within subsection (2) (b) of this section—

(i)the diploma is evidence of training which would satisfy the requirements of Article 2 of the Pharmacists Training Directive and is treated by the competent authorities of the member State in which it was awarded as equivalent to a diploma specified in Schedule 1A to this Act; or

(ii)the competent authorities of any member State have certified that the holder of the diploma has lawfully practised pharmacy for at least three consecutive years during the five years preceding the date of the certificate.]

[F11(3A)A diploma such as is mentioned in subsection (2)(c) of this section is not an appropriate European diploma for the purposes of this section unless—

(a)it entitles its holder to practise pharmacy throughout the territory of Germany on the same conditions as those applying to the holder of a diploma specified in paragraph 4(1) of Schedule 1A to this Act; and

(b)the competent authorities in Germany have certified that the holder of the diploma has lawfully practised pharmacy in Germany for at least three consecutive years during the five years preceding the date of the certificate.]

(4)Where under subsection (2) of section 2 of this Act it falls to the registrar or the Council to determine whether or not any of the conditions specified in subsection (3) of this section is satisfied in relation to any diploma—

(a)the satisfaction of the condition specified in paragraph (a)(i) of the said subsection (3) may be established by the production of a certificate of the competent authorities of the member State in relation to which the diploma is specified in Schedule 1A to this Act, or otherwise; and

[F12(aa)the satisfaction of the condition specified in paragraph (b)(i) of the said subsection (3), or paragraph (a) of subsection (3A), may be established by the production of a certificate of the competent authorities of the member State in which the diploma was awarded, or otherwise,]

(b)the satisfaction of the condition specified in paragraph (a)(ii) [F13or (b)(ii), or paragraph (b) of subsection (3A),] of the said subsection (3) shall be established by the production of the relevant certificate, and not otherwise.

(5)Where at any time during the period of the Greek derogation the name of any person is registered in respect of the qualification specified in paragraph 5 of Schedule 1A to this Act or in respect of any other diploma awarded in the Hellenic Republic—

(a)an indication that the registration is subject to the provisions of this subsection shall be entered in the register against that name; and

(b)the registration shall not authorise the person whose name is registered to do anything for which registration is required by any provision made by or under the Medicines Act M31968, the Misuse of Drugs Act M41971 or the Poisons Act M51972, except as an employed person.

(6)In this section and Schedule 1A to this Act—

  • competent authorities”, in relation to a member State, means any authority or body designated by that member State in accordance with Community Council Directive No. M685/433/EEC, as amended by Community Council Directive M785/584/EEC [F14and Community Council Directive 90/658/EEC M8], concerning the mutual recognition of diplomas, certificates and other evidence of formal qualifications in pharmacy;

  • employed person” means an employed person in accordance with Council Regulation (EEC) No. M91612/68 on freedom of movement for workers within the Community;

  • the implementation date”, in relation to a member State, means the date on which that State implemented the Pharmacists Training Directive;

  • national”, in relation to a member State, means the same as in the Community Treaties, but does not include a person who by virtue of Article 2 of Protocol No. 3 (Channel Islands and Isle of Man) to the Treaty of M10Accession is not to benefit from Community provisions relating to the free movement of persons and services;

  • the period of the Greek derogation” means the period during which the Hellenic Republic makes use of the derogation provided by paragraph 1 of Article 3 of Community Council Directive No. 85/433/EEC; and

  • the Pharmacists Training Directive” means Community Council Directive No. M1185/432/EEC concerning the co-ordination of provisions laid down by law, regulation or administrative action in respect of certain activities in the field of pharmacy.

(7)For the purposes of this section a member State is to be regarded as having implemented the Pharmacists Training Directive on the date notified to the Commission of the European Communities as that on which it did so.]

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F5S. 4A(1A) inserted (28.6.1996) by S.I. 1996/1405, reg. 2(2)

F6OJ No. L 257, 19.10.68, p. 2 (OJ/SE 1968 II) p. 475 amended by Council Regulation (EEC) No. 312/76 (OJ No. L039, 14.02.76, p. 2).

F7Word in s. 4A(2)(a) repealed (28.6.1996) by S.I. 1996/1405, reg. 2(3)

F8S. 4A(2)(c) inserted (28.6.1996) by S.I. 1996/1405, reg. 2(3)

F9Words in s. 4A(3)(a)(i) substituted (28.6.1996) by S.I. 1996/1405, reg. 2(4)(a)

F10S. 4A(3)(b) substituted (28.6.1996) by S.I. 1996/1405, reg. 2(4)(b)

F11S. 4A(3A) inserted (28.6.1996) by S.I. 1996/1405, reg. 2(5)

F12S. 4A(aa) inserted (28.6.1996) by S.I. 1996/1405, reg. 2(6)(a)

F13Words in s. 4A(4)(b) substituted (28.6.1996) by S.I. 1996/1405, reg. 2(6)(b)

F14Words in s. 4A(6) inserted (28.6.1996) by S.I. 1996/1405, reg. 2(7)

Modifications etc. (not altering text)

C1S. 4A restricted (31.3.1995) by S.I. 1995/414, reg. 5(13)

Marginal Citations

M6O.J. No. L253/37.

M7O.J. No. L372/42.

M8OJ No.L 353,17.12.90,p. 73

M9O.J. No. L257/2.

M10Cmnd. 5179–I/247.

M11O.J. No. L253/34.

5 Certificates of registration.E+W+S

(1)Subject to the provisions of the next following subsection, it shall be the duty of the Council, on the demand of any registered pharmaceutical chemist, to issue to him without fee a certificate of registration signed by the registrar and countersigned by either the President of the Society or two members of the Council.

(2)There shall be no obligation on the Council to issue a further such certificate as aforesaid to a person to whom such a certificate has already been issued, unless the person—

(a)satisfies the registrar that the original certificate, and any further certificate already issued to him, has been lost or destroyed; and

(b)pays to the Society such fee (if any) in respect of the further certificate as is prescribed.

[F15(3)Any certificate of registration issued to any person under this section shall reproduce any indication entered in the register against that person’s name in pursuance of section 4A(1) or (5)(a) of this Act.]

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

6 Evidence of registration.E+W+S

(1)Any document purporting to be a print of the Annual Register of Pharmaceutical Chemists printed and published by authority of the registrar in any year shall, at any time before the publication of the said Annual Register for the succeeding year, be admissible in any proceedings as evidence that any person named therein is, and that any person not named therein is not, a registered pharmaceutical chemist.

(2)Any such certificate as is mentioned in the last foregoing section shall be admissible in any proceedings as evidence that the person named therein as a registered pharmaceutical chemist is a registered pharmaceutical chemist.

Removal from and restoration to the register, etc.E+W+S

7 The Statutory Committee.E+W+S

For the purposes of this Act there shall be appointed a committee of the Society (to be known as “the Statutory Committee”), and the provisions of the First Schedule to this Act shall have effect in relation to the Statutory Committee.

8 Control of registrations by Statutory Committee.E+W+S

(1)Where—

(a)a person applying to have his name registered, or

(b)a registered pharmaceutical chemist or any person employed by him in the carrying on of his business, or

(c)a person whose name has been removed from the register under section twelve of this Act or any person employed by him as aforesaid,

has been convicted of any such criminal offence or been guilty of such misconduct (being in a case falling within paragraph (c) of this subsection a conviction or misconduct which took place either before or after the removal of the name) as in the opinion of the Statutory Committee renders the convicted or guilty person unfit to have his name on the register, the Committee may, after enquiring into the matter—

(i)in a case falling within paragraph (a) of this subsection, direct that the applicant’s name shall not be registered, or shall not be registered until the Committee otherwise directs;

(ii)in a case falling within paragraph (b) thereof, direct the registrar to remove the name of the registered pharmaceutical chemist from the register;

(iii)in a case falling within paragraph (c) thereof, direct that the name removed from the register shall not be restored thereto, or shall not be restored thereto until the Committee otherwise directs;

and, where the Committee directs that a name shall be removed from the register or shall not until the Committee otherwise directs be registered or restored to the register, the Committee may also direct that no application to the Committee in respect of its registration, or as the case may be its restoration to the register, shall be entertained thereafter until the expiration of such period as is specified in the direction or the fulfilment of such conditions as are so specified.

[F16(1A)Where the Statutory Committee is satisfied that any person is subject to a disqualifying decision the Committee shall be entitled to exercise its powers under subsection (1) of this section in relation to that person on the assumption that the grounds on which the decision was expressed to be made constitute such misconduct rendering that person unfit to have his name on the register as would (apart from this subsection) justify the exercise of those powers.

(1B)For the purposes of this section a person is subject to a disqualifying decision if—

(a)a decision is made in respect of that person by responsible authorities in a member State other than the United Kingdom;

(b)that decision has the effect in that State either that that person ceases to be registered or otherwise officially recognised to practise pharmacy in that State or that he is prohibited from practising pharmacy there;

(c)that decision is expressed to be made on the grounds that that person has committed a criminal offence or has been guilty of any misconduct.]

(2)Where the name of any person has been removed from the register in pursuance of a direction under paragraph (ii) of [F17subsection (1) of this section], the Committee may, either of its own motion or on the application of that person, direct the registrar to restore the name to the register, either without fee or on the payment to the Scoeity of such fee as is prescribed in that behalf, not exceeding the fee prescribed for registration in pursuance of section three of this Act.

(3)It shall be the duty of the Statutory Committee—

(a)to give notice of any direction under this section to the person to whom the direction relates;

(b)to give notice of any refusal of an application made under the last foregoing subsection to the applicant;

and any notice required by this subsection to be given to any person shall be given by being sent to him in a registered letter which, in the case of a registered pharmaceutical chemist, shall be addressed to his address on the register.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F17Words substituted by S.I. 1987/2202, art. 2(6)

9 Restriction on directions by Statutory Committee.E+W+S

(1)No direction (other than a direction authorising the registration or restoration to the register of a name) shall be given by the Statutory Committee under subsection (1) of the last foregoing section without the assent of the chairman of the Committee.

(2)Where an act or omission which, under the last foregoing section, may be made the ground of a direction by the Statutory Committee involving the cesser or restriction of the right of a person to have his name registered is an act or omission on the part of an employee of that person, the Committee shall not give any such direction unless proof is given to its satisfaction of some one or more of the facts specified in the next following subsection and the Committee is of opinion that, having regard to the facts so proved, the said person ought to be regarded as responsible for the act or omission.

(3)The facts as to some one or more of which the Committee must be satisfied before giving any such direction as is mentioned in subsection (2) of this section are—

(a)that the act or omission in question was instigated or connived at by the said person;

(b)that the said person or any employee of his had been guilty at some time within twelve months before the date on which the act or omission in question took place of a similar act or omission and that the said person had, or reasonably ought to have had, knowledge of that previous act or omission;

(c)if the act or omission in question was a continuing act or omission, that the said person had, or reasonably ought to have had, knowledge of the continuance thereof;

(d)in the case of a criminal offence being an offence under the Pharmacy Acts, that the said person had not used due diligence to enforce the execution of those Acts.

10 Appeals against directions, etc.E+W+S

(1)A person aggrieved by a direction of the Statutory Committee under section eight of this Act or the refusal of an application made under subsection (2) of that section may at any time within three months from the date on which notice of the direction or, as the case may be, of the refusal is given to him appeal to the High Court against the direction or refusal; and the Society may appear as respondent on any such appeal.

(2)The High Court may on any such appeal make such order as the court thinks fit in the matter including an order as to the costs of the appeal and in particular as to the payment of any such costs by the Society, whether or not the Society appear on the hearing of the appeal; and the order of the High Court on any such appeal shall be final.

(3)It shall be the duty of the registrar to make such alterations in the register as are necessary to give effect to any such order as aforesaid.

11 Time of operation etc. of certain directions.E+W+S

(1)A direction under paragraph (ii) of subsection (1) of section eight of this Act shall not take effect until the expiration of three months from the giving of notice of the direction as required by subsection (3) of that section or, where an appeal to the High Court is brought against the direction, until the appeal is determined or withdrawn.

(2)If the High Court has dismissed an appeal against a direction under the said subsection (1) that a name shall be removed from the register or shall not, until the Committee otherwise directs, be registered or restored to the register, a direction by the Committee authorising the registration or restoration of the name shall not take effect unless it is approved by the Privy Council.

(3)When any direction under the said section eight takes effect it shall be the duty of the registrar to make such alterations in the register as are necessary to give effect to the direction.

12 Removal from register for non-payment of retention fee, etc.E+W+S

(1)If any registered pharmaceutical chemist on whom a demand has been made in the prescribed manner for the payment of any fee payable by him under subsection (3) of section two of this Act fails to pay the fee within two months from the date of the demand, the Council may direct the registrar to remove the chemist’s name from the register.

(2)If any person whose name has been removed from the register under the last foregoing subsection for non-payment of any fee pays to the Society, before the expiration of the year in respect of which the fee is payable or of such longer period as the Council allow, the fee and such additional sum (if any) by way of penalty as is prescribed, it shall be the duty of the registrar, subject to the provisions of any direction in force under paragraph (iii) of subsection (1) of section eight of this Act, to restore that person’s name to the register.

(3)Where a name removed from the register under subsection (1) of this section is restored thereto under the last foregoing subsection, the restoration shall, if the Council so direct, have effect from the date of the removal of the name.

13 Corrections of the register.E+W+S

(1)It shall be the duty of the registrar—

(a)to remove from the register the name of any registered pharmaceutical chemist who has died;

(b)to remove from the register any entry which the Council, by an order in writing, direct him to remove therefrom as being in their opinion an entry which was procured by fraud;

(c)to correct in accordance with the Council’s directions any entry in the register which the Council, by an order in writing, direct him to correct as being in their opinion an entry which was incorrectly made; and

(d)to make from time to time any necessary alterations in the registered particulars of registered pharmaceutical chemists.

(2)The registrar may remove from the register any name to which this subsection applies by virtue of subsection (4) of this section, and the Council may direct the registrar to restore to the register any name removed therefrom under this subsection.

(3)Every registrar of births and deaths shall, on registering the death of a pharmaceutical chemist, send forthwith by post to the registrar under this Act a copy certified under his hand of the entry relating to the death in the register of deaths; and the cost of the certificate and of sending it by post shall be payable by the registrar under this Act to the registrar of births and deaths from whom it is received.

(4)If the registrar—

(a)sends by post to any registered pharmaceutical chemist a registered letter addressed to him at his address on the register enquiring whether he has ceased to practise as a pharmaceutical chemist or has changed his address and receives no reply to the letter within the period of six months from the date of posting it; and

(b)upon the expiration of that period sends in like manner to the pharmaceutical chemist in question a second similar letter and receives no reply to that letter within three months from the date of posting it,

subsection (2) of this section shall apply to the name of the registered pharmaceutical chemist in question.

Prospective

[F18 Imposition of practising conditions and suspension from the registerE+W+S

F1913A The Health Committee.E+W+S

(1)There shall be appointed a committee of the Society, to be known as the Health Committee.

(2)The provisions of Schedule 1B to this Act shall have effect in relation to the Health Committee.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F19S. 13A inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2013B Preliminary investigation by the Council.E+W+S

(1)This section applies to an allegation to the effect that the ability of a registered pharmaceutical chemist to practise as a pharmaceutical chemist is seriously impaired because of his physical or mental condition.

(2)Where such an allegation is made or referred to the Council, they shall —

(a)notify the pharmaceutical chemist of the allegation and invite him to give them his observations before the end of the permitted period,

(b)take such steps as are reasonably practicable to obtain as much information as possible about the case, and

(c)consider, in the light of the information which they have been able to obtain and any observations duly made to them by the pharmaceutical chemist, whether in their opinion there is a case to answer.

(3)In subsection (2)(a) of this section “the permitted period” means—

(a)the period of 28 days beginning with the day on which notice of the allegation is sent to the pharmaceutical chemist, or

(b)where the Council consider that, were the allegation to be well founded, it would be necessary for members of the public to be protected without delay, such shorter period as may be specified by the Council in regulations.

(4)Where the Council conclude that there is a case to answer, they shall—

(a)notify the pharmaceutical chemist of their conclusion, and

(b)refer the allegation, as formulated by them, to the Health Committee.

(5)Where the Council conclude that there is no case to answer, they shall notify the pharmaceutical chemist of their conclusion.

(6)The Council may make regulations with respect to the procedure to be followed on an investigation under this section.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F20S. 13B inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2113C Conditions of practice orders and suspension orders.E+W+S

(1)The Health Committee shall consider an allegation against a pharmaceutical chemist referred to them under section 13B of this Act.

(2)If, having considered the allegation, the Committee is satisfied that it is well founded, the Committee shall—

(a)make an order imposing conditions with which the pharmaceutical chemist must comply while practising as a pharmaceutical chemist (a “conditions of practice order”), or

(b)make an order directing the registrar to suspend the pharmaceutical chemist’s registration for the period specified in the order (a “suspension order”).

(3)Any condition in a conditions of practice order shall have effect for the period specified in the order.

(4)The period specified in a conditions of practice order or a suspension order shall not exceed three years.

(5)An order under this section shall have effect—

(a)if there is no appeal against it under section 13J of this Act, when the period for making such an appeal expires, or

(b)if there is an appeal against it under that section, when the appeal is withdrawn or otherwise disposed of.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F21S. 13C inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2213D Review of orders.E+W+S

(1)The Health Committee may review a conditions of practice order or a suspension order made with respect to a pharmaceutical chemist at any time while the order has effect.

(2)The Committee shall review such an order on the written application of the pharmaceutical chemist.

(3)The Committee shall not consider an application under subsection (2) of this section for a review of an order if—

(a)the pharmaceutical chemist has made an earlier application under that subsection for a review of the order,

(b)the earlier application was made within the period of twelve months ending with the date on which the Committee received the application, and

(c)the order was not varied on the earlier review.

(4)On a review under subsection (1) of this section of a conditions of practice order, the Committee may—

(a)confirm the order,

(b)revoke the order,

(c)vary the order, or

(d)replace the order with a suspension order.

(5)On a review under subsection (1) of this section of a suspension order, the Committee may—

(a)confirm the order,

(b)revoke the order,

(c)vary the order,

(d)replace the order with a conditions of practice order, or

(e)make a conditions of practice order with which the pharmaceutical chemist must comply if he resumes practice as a pharmaceutical chemist after the end of his period of suspension.

(6)On a review under subsection (1) of this section, an order may be varied by—

(a)extending (or further extending) or reducing the period specified in the order, or

(b)in the case of a conditions of practice order, imposing additional conditions or removing or altering any of the existing conditions,

but the period specified in the order may not be extended (or further extended) by more than three years.

(7)On a review under subsection (2) of this section, the Committee may—

(a)confirm the order,

(b)revoke the order, or

(c)vary the order.

(8)On such a review, an order may be varied by—

(a)reducing the period specified in the order, or

(b)in the case of a conditions of practice order, removing or altering any of the conditions.

(9)If an order is revoked on a review under this section without being replaced by another order, the revocation shall have immediate effect.

(10)Any other decision on a review under this section shall have effect—

(a)if there is no appeal against it under section 13J of this Act, when the period for making such an appeal expires, or

(b)if there is an appeal against it under that section, when the appeal is withdrawn or otherwise disposed of.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F22S. 13D inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2313E Exercise by Health Committee of its powers.E+W+S

In exercising any power to make, confirm, vary or revoke a conditions of practice order or a suspension order, the Health Committee shall ensure that any conditions imposed on the pharmaceutical chemist are, or any period of suspension imposed on him is, the minimum which it considers necessary for the protection of members of the public.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F23S. 13E inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2413F Interim suspension orders.E+W+S

(1)Where the Health Committee makes a suspension order with respect to a pharmaceutical chemist, it may make an order directing the registrar to suspend the pharmaceutical chemist’s registration with immediate effect (an “interim suspension order”).

(2)The Committee may only make an interim suspension order if it is satisfied that it is necessary to do so in order to protect members of the public.

(3)If there is no appeal against the suspension order under section 13J of this Act, an interim suspension order shall cease to have effect when the period for making such an appeal expires.

(4)If there is an appeal against the suspension order under that section, an interim suspension order shall cease to have effect—

(a)when the appeal is withdrawn or otherwise disposed of, or

(b)(if sooner) at the end of the period of 12 weeks beginning with the day on which the interim suspension order is made.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F24S. 13F inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2513G Procedural regulations.E+W+S

(1)The Council shall make regulations as to the procedure to be followed—

(a)on the consideration of an allegation against a pharmaceutical chemist under section 13C of this Act, and

(b)on a review under section 13D of this Act of an order made with respect to a pharmaceutical chemist.

(2)The regulations shall, in particular, include provision—

(a)requiring the pharmaceutical chemist to be given notice of the allegation or review,

(b)giving the pharmaceutical chemist an opportunity to put his case at a hearing,

(c)entitling the pharmaceutical chemist to be legally represented at any hearing in respect of the allegation or review,

(d)enabling such a hearing to be held in the absence of the pharmaceutical chemist if the requirements of regulations made by virtue of paragraphs (a) to (c) of this subsection have been met,

(e)securing that such a hearing is held in private unless—

(i)the pharmaceutical chemist requires the hearing or any part of it to be held in public, or

(ii)the Health Committee considers that it is appropriate to hold the hearing or any part of it in public,

(f)requiring the pharmaceutical chemist to be notified by the Committee of its decision, its reasons for reaching that decision and of his right of appeal,

(g)giving the Committee power to require persons to attend and give evidence or to produce documents,

(h)about the admissibility of evidence, and

(i)enabling the Committee to administer oaths.

(3)No person shall be required by any regulations made under this section to give any evidence or produce any document or other material at a hearing in respect of the allegation or review which he could not be compelled to give or produce in civil proceedings in any court in the part of Great Britain in which the hearing takes place.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F25S. 13G inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2613H Duties of registrar in relation to orders, etc.E+W+S

(1)Where a conditions of practice order is made, the registrar shall enter in the register a note of—

(a)the conditions imposed, and

(b)the period for which each condition is to have effect.

(2)Where a suspension order is made, the registrar shall enter in the register a note of—

(a)the suspension, and

(b)the period of the suspension.

(3)Where a conditions of practice order or a suspension order is revoked or varied on a review under section 13D of this Act or an appeal under section 13J of this Act, the registrar shall delete, or make the necessary alterations to, any note entered in the register under subsection (1) or (2) of this section.

(4)Where an interim suspension order is made, the registrar shall enter in the register a note of the suspension.

(5)When an interim suspension order ceases to have effect, the registrar shall delete the note entered in the register under subsection (4) of this section.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F26S. 13H inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2713I Effect of suspension of registration.E+W+S

(1)A pharmaceutical chemist who is subject to a suspension order or an interim suspension order shall be treated as if his name was not registered for the purposes of—

(a)sections 2, 5 and 14 of, and paragraphs 2(3) of Schedule 1B and 3(2) of Schedule 1C to, this Act,

(b)sections 10, 23, 31, 33 and 52 of the M12Medicines Act 1968,

(c)section 7 of the M13Misuse of Drugs Act 1971,

(d)the M14Poisons Act 1972,

(e)paragraph 1 of Schedule 9 to the M15National Health Service Act 1977, and

(f)paragraph 1 of Schedule 8 to the M16National Health Service (Scotland) Act 1978.

(2)For the purposes of this section a pharmaceutical chemist is subject to an order during the period for which the order has effect.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F27S. 13I inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

Marginal Citations

F2813J Appeals against decisions of the Health Committee.E+W+S

(1)A pharmaceutical chemist with respect to whom an appealable decision is made by the Health Committee may appeal against the decision.

(2)In subsection (1) of this section “appealable decision” means—

(a)a conditions of practice order,

(b)a suspension order,

(c)variation of an order on a review under section 13D of this Act, or

(d)replacement of an order with another order on such a review.

(3)An appeal under this section may not be made after the end of the period of 28 days beginning with the date on which notification of the decision is sent to the pharmaceutical chemist.

(4)An appeal under this section lies to an appeal tribunal established for the purpose of the appeal by the Privy Council.

(5)The provisions of Schedule 1C to this Act shall have effect in relation to appeal tribunals established under this section.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F28S. 13J inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F2913K Procedure on appeals.E+W+S

(1)In this section “an appeal” means an appeal made by a pharmaceutical chemist under section 13J of this Act to an appeal tribunal established under that section.

(2)An appeal shall be by way of a rehearing of the case.

(3)The Council shall be the respondent to an appeal.

(4)The Council shall make regulations as to the procedure to be followed on an appeal.

(5)The regulations shall, in particular, include provision—

(a)as to the manner in which the appeal is to be made,

(b)giving the pharmaceutical chemist an opportunity to put his case at a hearing,

(c)entitling the pharmaceutical chemist to be legally represented at any hearing in respect of the appeal,

(d)enabling such a hearing to be held in the absence of the pharmaceutical chemist if the requirements of regulations made by virtue of paragraphs (a) to (c) of this subsection have been met,

(e)securing that such a hearing is held in private unless the pharmaceutical chemist or the Council require it to be held in public,

(f)requiring the pharmaceutical chemist to be notified by the appeal tribunal of its decision and its reasons for reaching that decision,

(g)giving the appeal tribunal power to require persons to attend and give evidence or to produce documents,

(h)about the admissibility of evidence, and

(i)enabling the appeal tribunal to administer oaths.

(6)No person shall be required by any regulations made under subsection (4) of this section to give any evidence or produce any document or other material at a hearing in respect of an appeal which he could not be compelled to give or produce in civil proceedings in any court in the part of Great Britain in which the hearing takes place.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F29S. 13K inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F3013L Decisions of appeal tribunals.E+W+S

(1)This section applies where an appeal is made by a pharmaceutical chemist under section 13J of this Act to an appeal tribunal established under that section.

(2)The appeal tribunal may—

(a)confirm a conditions of practice order or suspension order,

(b)revoke such an order,

(c)vary such an order,

(d)replace a conditions of practice order with a suspension order,

(e)replace a suspension order with a conditions of practice order, or

(f)make a conditions of practice order with which the pharmaceutical chemist must comply if he resumes practice as a pharmaceutical chemist after the end of his period of suspension.

(3)An order may be varied by—

(a)extending or reducing the period specified in the order, or

(b)in the case of a conditions of practice order, imposing additional conditions or removing or altering any of the existing conditions,

but the period specified in the order may not be extended by more than three years.

(4)Section 13E of this Act shall apply to an appeal tribunal as it applies to the Health Committee.

(5)The appeal tribunal may award costs or expenses.

(6)Any decision of the appeal tribunal may be made by a majority of its members.

(7)A decision of the tribunal on an appeal shall have effect when notification of it is sent to the pharmaceutical chemist.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F30S. 13L inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

F3113M Approval of regulations.E+W+S

(1)No regulations made under section 13B, 13G or 13K of this Act shall come into operation until they are approved by the Privy Council by order made by statutory instrument.

(2)Any statutory instrument made under this section shall be subject to annulment in pursuance of a resolution of either House of Parliament.]

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F31S. 13M inserted (prosp.) by 1997 c. 19, ss. 1, 2, Sch. para. 2 (with s. 1)

Miscellaneous provisions relating to the Pharmaceutical SocietyE+W+S

14 Membership of the Society.E+W+S

Every person whose name is registered shall, by virtue of the registration, be a member of the Society, and shall, on his name ceasing to be registered, cease to be a member of the Society.

15 Appointment of additional members of Council.E+W+S

(1)The Privy Council may appoint three persons to be members of the Council of the Society in addition to the persons elected as members of the Council under the Society’s Charter, and the persons appointed by the Privy Council under this section shall hold office as members of the Council for such period as the Privy Council determine.

(2)A person may be appointed under this section as a member of the Council whether he is or is not a member of the Society.

16 Byelaws.E+W+S

The Council may make such byelaws as they think necessary for the purposes of any provision of this Act referring to byelaws; but no byelaw made by virtue of this Act shall come into operation until it is approved by the Privy Council.

17 The benevolent fund.E+W+S

The Council may, out of the property of the Society and out of any property for the time being comprised in the benevolent fund established in pursuance of the Society’s Charter of Incorporation, make provision for such purposes relating to the relief of distressed persons, being—

(a)members of the Society;

(b)persons who at any time have been such members or have been registered as pharmaceutical chemists or chemists and druggists under this Act or any enactment repealed by, or by an enactment repealed by, this Act;

(c)widows, orphans and other dependants of deceased persons who were at any time members of the Society or registered as aforesaid; or

(d)students of the Society,

as the Council may, subject to byelaws, determine.

OffencesE+W+S

18 Falsifications by the registrar.E+W+S

If the registrar wilfully makes or causes to be made any falsification in any matter relating to the register or the Annual Register of Pharmaceutical Chemists or any such certificate as is mentioned in subsection (5) of section three of this Act, he shall be guilty of a misdemeanour and, in the case of a falsification relating to the said Annual Register, liable to imprisonment for a term not exceeding twelve months.

19. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F32E+W+S
Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

20 Offences relating to certificates.E+W+S

(1)If any person fraudulently exhibits any certificate purporting to be a certificate of membership of the Society, he shall be guilty of a misdemeanour.

(2)If, with intent to deceive, any person—

(a)[F33forges, or] uses, or lends to or allows to be used by any other person any certificate issued under the Pharmacy Acts; or

(b)makes or has in his possession any document so closely resembling such a certificate as to be calculated to deceive,

he shall be liable on summary conviction, in respect of each offence, to a fine not exceeding [F34level 3 on the standard scale] and, in the case of a continuing offence, to a further fine not exceeding five pounds for every day subsequent to the day on which he is convicted of the offence during which the contravention continues.

  • [F35In the application of this subsection to England or Wales, the expression “forges” has the same meaning as in the M17Forgery Act 1913.]

(3)If any person to whom a certificate of registration has been issued in pursuance of section five of this Act ceases to be a registered pharmaceutical chemist he shall, before the expiration of fourteen days from so ceasing, transmit the certificate to the registrar for cancellation, and, if he fails to do so, he shall be liable on summary conviction, in respect of each offence, to a fine not exceeding [F36level 1 on the standard scale] and to a further fine not exceeding one pound for every day subsequent to the day on which he is convicted of the offence during which the default continues.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

Modifications etc. (not altering text)

Marginal Citations

21 Extension of time for certain prosecutions.E+W+S

Notwithstanding anything in [F37the Magistrates’ Courts Act 1980] or [F38the M18Criminal Procedure (Scotland) Act 1975] proceedings for an offence under F39. . .subsection (2) or subsection (3) of the last foregoing section may be commenced at any time within the period of twelve months next after the date of the commission of the offence.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F38Words substituted by virtue of Interpretation Act 1978 (c. 30), s. 17(2)(a)

F39Words in s. 21 repealed (5.11.1993) by 1993 c. 50, s. 1(1), Sch. 1 Pt.XII.

Marginal Citations

SupplementalE+W+S

22 Exercise of powers conferred on Privy Council.E+W+S

(1)For the purpose of exercising any powers conferred by this Act on the Privy Council, the quorum of the Privy Council shall be three.

(2)Any document purporting to be—

(a)an instrument of appointment or approval made by the Privy Council under this Act or any other instrument so made; and

(b)signed by the Clerk of the Privy Council or by any other person authorised by the Privy Council in that behalf,

shall be evidence of the fact that the instrument was so made and of the terms of the instrument.

23 Application of fees, etc.E+W+S

Any sum received by the Society by way of fee or penalty in pursuance of any provision of this Act shall be applicable for the purposes of the Society.

24 Interpretation.E+W+S

(1)In this Act, unless the context otherwise requires, the following expressions have the meanings hereby assigned to them respectively, that is to say—

  • F40. . .

  • byelaws” means byelaws made by the Council;

  • the Council” means the Council of the Society;

  • [F41the Pharmacy Acts” means F42. . . the M19Pharmacy Act 1954, sections 77 and 84(1) of the M20Medicines Act 1968 and the M21Poisons Act 1972, and includes rules made F42. . . under section 7 of the Poisons Act 1972].

  • prescribed” means prescribed by byelaws;

  • the register” means the Register of Pharmaceutical Chemists F42. . . maintained in pursuance of subsection (1) of section two of this Act;

  • registered” means registered in the register, and “to register” and “registration” shall be construed accordingly;

  • registered pharmaceutical chemist” means a person whose name is registered;

  • registrar” means the registrar appointed in pursuance of section one of this Act;

  • the Society” means the Pharmaceutical Society of Great Britain;

  • “year”, in subsection (3) of section two and subsection (2) of section twelve, means a period of twelve months beginning on such date as is for the time being determined by the Council.

(2)In the application of this Act to Scotland any reference to the High Court shall be construed as a reference to the Court of Session.

(3)Any reference in this Act to any enactment is a reference to that enactment as amended by any subsequent enactment.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F40Definition in s. 24(1) of "the Act of 1933" repealed (5.11.1993) by 1993 c. 50, s. 1(1), Sch.XII.

F41Definition substituted by Poisons Act 1972 (c. 66), s. 12(2)

F42Words in s. 24(1) repealed (5.11.1993) by 1993 c. 50, s. 1(1), Sch.XII.

Marginal Citations

F4325. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E+W+S

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F43S. 25 repealed (5.11.1993) by 1993 c. 50, s. 1(1), Sch. 1 Pt.XII.

26 Short title, commencement and extent.E+W+S

(1)This Act may be cited as the Pharmacy Act 1954, and shall come into operation at the expiration of one month beginning with the date of its passing.

(2)This Act shall not extend to Northern Ireland.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enactedversion that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources